Stay updated with breaking news from Systems Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The researchers reveal that this is a major trial for the rare and debilitating condition IIH that can lead to people going blind and suffering disabling daily headaches.
A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes.
Get latest articles and stories on Health at LatestLY. A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes. Health News | New Medicine to Lower Brain Pressure Might Treat Blinding IIH Headaches: Study.
A study for idiopathic intercranial hypertension is the first to show rapid and a major reduction in brain pressure and monthly headaches.
Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension could be treated with an injectable peptide used for type 2 diabetes, a new trial has found.